. ▁The ▁Institute ▁for ▁Systems ▁Bi ology ▁has ▁used ▁this ▁technology ▁to ▁sequence ▁ 6 1 5 ▁complete ▁human ▁gen ome ▁samples ▁as ▁part ▁of ▁a ▁survey ▁studying ▁ne uro de gener ative ▁dise ases , ▁and ▁the ▁National ▁Can cer ▁Institute ▁is ▁using ▁DNA ▁nan ob all ▁sequ encing ▁to ▁sequence ▁ 5 0 ▁tum ours ▁and ▁matched ▁normal ▁t issues ▁from ▁ped iat ric ▁can cers . ▁ ▁Sign ific ance ▁ ▁Mass ively ▁parallel ▁next ▁generation ▁sequ encing ▁platforms ▁like ▁DNA ▁nan ob all ▁sequ encing ▁may ▁contribute ▁to ▁the ▁diagn osis ▁and ▁treatment ▁of ▁many ▁gen etic ▁dise ases . ▁The ▁cost ▁of ▁sequ encing ▁an ▁entire ▁human ▁gen ome ▁has ▁fallen ▁from ▁about ▁one ▁million ▁dollars ▁in ▁ 2 0 0 8 , ▁to ▁$ 4 4 0 0 ▁in ▁ 2 0 1 0 ▁with ▁the ▁DNA ▁nan ob all ▁technology . ▁Se qu encing ▁the ▁entire ▁genom es ▁of ▁patients ▁with ▁her itable ▁dise ases ▁or ▁cancer , ▁mut ations ▁associated ▁with ▁these ▁dise ases ▁have ▁been ▁identified , ▁opening ▁up ▁strateg ies , ▁such ▁as ▁target ed ▁th era pe ut ics ▁for ▁at - ris k ▁people ▁and ▁for ▁gen etic ▁coun sel ing . ▁ ▁As ▁the ▁price ▁of ▁sequ encing ▁an ▁entire ▁human ▁gen ome ▁approaches ▁the ▁$ 1 0 0 0 ▁mark , ▁genom ic ▁sequ encing ▁of ▁every ▁individual ▁may ▁become ▁feas ible ▁as ▁part ▁of ▁normal ▁prevent ative ▁medicine . ▁ ▁References ▁▁ ▁Category : D NA ▁sequ encing